Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Azenta Life Sciences provides enterprise-grade sample discovery, storage, and management solutions for the life sciences industry. Based on the website content, it is not a standalone SaaS tool, but rather a vertical industry solution that combines cloud-based LIMS, inventory management, cryogenic equipment monitoring, automated storage systems, consumables, and sample storage services. Its goal is to accelerate drug discovery, development, and delivery.
On the software side, the key offerings include Limfinity Biobanking LIMS, Limfinity Cell Line LIMS, FreezerPro Inventory Management, and Cryo Monitoring Portal. Limfinity is described as a “cloud-based laboratory information management system” and can integrate with an organization’s existing digital ecosystem. Cryo Monitoring Portal is used to track the status of cryogenic freezers and equipment in real time from any location. On the hardware and services side, the offering covers automated refrigerated storage, -80°C ultra-low temperature storage, -190°C cryogenic storage, Mirage Connect intelligent sample tracking, GMP storage, clinical trial support, laboratory relocation, and more.
The publicly available content does not provide standard plans, per-user pricing, or subscription fees. It is presented more as a contact-sales or project-based procurement model. The page includes a “Pricing & Other” entry point and discloses several promotions, such as a 50% discount on software packages with qualifying CryoArc Pico purchases, discounts on selected consumables, and a trade-in program for code readers.
Its strengths lie in its clear industry depth, covering the full sample lifecycle from identification, storage, and monitoring to outsourced management. It is well suited for complex scenarios such as biobanks, pharmaceutical companies, and cell/gene therapy. The cloud-based LIMS and real-time cryogenic monitoring can help improve sample traceability and operational efficiency. The downside is that the public information lacks details on permission systems, audit trails, data security certifications, APIs, SLAs, and specific integration targets, so further documentation is still needed for software procurement evaluation.
It is better suited for laboratories, pharmaceutical companies, CRO/clinical trial teams, and research institutions with large sample volumes, cryogenic equipment, and compliance requirements. For ordinary lightweight labs that only need simple inventory management, it may feel overly heavy. Access from China cannot be determined from the available content and is marked as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on 150.today official site.
150.today is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach 150.today directly.